Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 1/20 | 0.61 |
| ▸ | RAB9A | P51151 | 4/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.51 |
| ▸ | NPC1 | O15118 | 3/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | EPHX1 | P07099 | 3/20 | 0.48 |
| ▸ | HPGD | P15428 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | SLC5A7 | Q9GZV3 | 7/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6409949 | 0.84 | EPHX2 (0.57) | EPHX2RAB9ASMN1; SMN2NPC1ALDH1A1 | |
| SCHEMBL6401607 | 0.82 | EPHX2 (0.57) | EPHX2RAB9ASMN1; SMN2NPC1ALDH1A1 | |
| SCHEMBL6402627 | 0.81 | EPHX1 (0.51) | EPHX2RAB9ASMN1; SMN2NPC1ALDH1A1 | |
| SCHEMBL6409359 | 0.81 | RAB9A (0.59) | RAB9ASMN1; SMN2NPC1TSHRALDH1A1 | |
| SCHEMBL6406584 | 0.80 | EPHX1 (0.50) | EPHX2RAB9ASMN1; SMN2NPC1ALDH1A1 | |
| SCHEMBL6404969 | 0.80 | EPHX1 (0.50) | EPHX2RAB9ASMN1; SMN2NPC1ALDH1A1 | |
| SCHEMBL6407673 | 0.80 | EPHX1 (0.50) | EPHX2RAB9ASMN1; SMN2NPC1ALDH1A1 | |
| SCHEMBL6404204 | 0.80 | RAB9A (0.50) | EPHX2RAB9ASMN1; SMN2NPC1ALDH1A1 | |
| SCHEMBL6405207 | 0.80 | SMN1; SMN2 (0.47) | EPHX2RAB9ASMN1; SMN2NPC1TSHR | |
| SCHEMBL6407578 | 0.79 | EPHX1 (0.48) | EPHX2RAB9ASMN1; SMN2NPC1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050171358-A1 | Substituted isoxazole alkylamine derivative and agri-and horticultural fungicide | SDS BIOTECH K.K. (JP) | 2005-08-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050171358-A1 | Substituted isoxazole alkylamine derivative and agri-and horticultural fungicide | AHR, ERG28, CYP1A2 | EPHX2 2961/4885RAB9A 4044/4885SMN1; SMN2 4458/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.